Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems

Sponsored by:

Date:

December 14, 2022

Time (PT):

11:00 AM

Duration (min):

Deepak Sahu, MBA, explains how HEOR studies are important for generating useful effectiveness data for success of medical technologies.

Adoption, utilization, and payment of medical technologies require safety, efficacy, and effectiveness data to convince the purchaser (provider, payer, or patient). In the United States (US) healthcare system, long-term data on effectiveness is critical to maintain payer confidence in the technology and serve the population. Therefore, a well-designed Health Economics and Outcomes Research (HEOR) study is vital for generating short- and long-term effectiveness data. In addition, this webinar discusses a stepwise strategic approach to developing HEOR data for medical technology.

Presenters

Deepak Sahu

Alira Health

Partner

Deepak Sahu, MBA, focuses on public health and has a strong background in healthcare solutions development. He has more than five years of strategy consulting and project management experience from engagements in Japan, US, and Europe. Deepak holds an MBA from ESB Business School in Germany and Bachelors in Computer Science.

Alira Health

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle, from development to medical care, through real-world evidence.

Content Partners

HealthEconomics.com

HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.

HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.

Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.

Topics

Health Economics & Outcomes Research (HEOR)

Medical Communications

Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems

Presenters

Deepak Sahu

Sponsor

Alira Health

Content Partners

HealthEconomics.com

Topics

Watch Now

Related Content

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Network meta-analysis and its role in evidence-based decision-making

Network meta-analysis and its role in evidence-based decision-making

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Market Access - Transforming BioTech Commercial Decisions?

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Pharma can target ultra-rare conditions ‚Äî the next step is financing them

Advancing identity data management for digital engagement: How leading organizations are doing it

Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model

Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change

Closing the gaps of getting data to make decisions

The role of patient-centric technologies & tokenization in RWE studies

How Digital Health Can Empower Cancer Patients

Clinical Trial Innovation: How Healthcare Technology is Evolving

Connected communities: Advancing population health through data and emerging technology

Certified Corporate Wellness Specialist(CCWS): Is It For Me?

The reimagined hospital: How health systems are keeping up with new tech

L7|LIVE SF - Tuesday, June 13th, 2023

Transforming Healthcare Using Big Data and Remote Monitoring

Synthesise RWE and AI. Transform patient-driven healthcare

Endpoints at #DIA23

From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer

Ushering in the new era of payvider integration

Keeping pace with the evolving global landscape in vaccine development

Partnering with NHS in a crisis: The role for industry

Unlock the Power of Data Review & Collaboration: Maximizing Trial Success

HTA Implementation in the MEA Region - an Overview from WHO and Country Updates

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

How to Supercharge Real World Evidence Generation in Phase IV Trials

HEOR Writing: The Ins and Outs of Value Communications

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

FDA Patient-Focused Drug Development (PFDD) Guidance

Creating Digital Biomarkers with Real-World and Existing Data by Xtalks

Beyond the payment variance report: How to resolve common, costly underpayment issues

Webcast: Strategies to Simplify Insurance Discovery

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

Measuring the intangible- what is the true value of a "patient centric" initiative

Champion a seamless end-to-end insight generation process

Different HTA Perspectives on Reliably Estimating Treatment Effects

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

Fit for Local Context? Establishing or Improving Deliberative Processes for HTA

Evidence Matters 2022

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

Cell & Gene Day 2022 | Virtual Event | August 24th

Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT

Confronting care inequities in hospital medicine - August 18th, 2022

Pain R&D: Plenty of pain to go around, but who's making gains?

AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th

Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making

Selecting Rapid Review Methods for Health Technology Assessment

Predicting Payer Uptake with Precision

It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability

Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality

Career Transitions: From Post-grad to Employee

Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews

Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy